Cambrian Bio is a clinical-stage drug development company focused on creating therapeutics designed to prevent diseases and lengthen healthspan. It emphasizes aging biology and the development of medicines to modify the course of chronic diseases, aiming to modernize healthcare in the 21st century. The company collaborates with scientists and operates across the biomedical innovation ecosystem to bring new medicines from research to clinical testing.
No recent news for this company.
No recent deals for this company.